
Quieting the brain’s immune cells
In a recent study, Prof. Steffen Jung and his research group explored the role of an anti-inflammatory protein known as interleukin-10 (IL-10)—already known to help quell overactive gut macrophages and other overexcited immune cells in the body—in helping brain microglia return to their normal, resting state following activation. Using a mouse model of neural system challenge, the researchers demonstrated that the ability of microglia to sense IL-10 is in fact key to a return to quiescence. If the microglia are ‘blinded’ to IL-10 (e.g., lacking the appropriate receptors), various forms of neural pathology result.
Curiously, the Jung group found that IL-10 is produced not by microglia themselves, but by other immune cells, such as NK cells and neutrophils. Excited microglia produce a different substance, known as TNF, which causes inflammation. When microglia lack the ability to sense IL-10, they overproduce TNF, resulting in different forms of brain pathology. However, Prof. Jung and his group also found that by eliminating TNF, they could prevent the development of disease, even if the microglia remain blind to IL-10—in effect, there’s no extinguisher for the fire, but there’s also limited fuel, and in time, things quiet down. These findings appeared in the November 2020 issue of Immunity.